Pfizer CEO McKinnell Says OTCs Still Provide Value
This article was originally published in The Tan Sheet
Consumer healthcare products remain key to Pfizer's strategic plan, Chairman & CEO Hank McKinnell maintained during a speech at the National Press Club May 17
You may also be interested in...
An FDA decision to request revised safety labeling changes to OTC NSAIDs enables manufacturers to continue positioning the drugs as safer alternatives to their prescription counterparts, which will carry "black box" warnings going forward
Pfizer does not consider its consumer business to be key to the company's strategic outlook during the 2005 "transition" year, CEO Hank McKinnell indicated during an April 5 business review with analysts
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC